Development
Tenet Healthcare Corporation
THC
$172.02
-$0.34-0.20%
NYSE
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 139.22% | -22.90% | 223.68% | 2.14% | -59.04% |
| Total Depreciation and Amortization | 1.41% | 7.18% | -1.39% | 6.90% | 5.97% |
| Total Amortization of Deferred Charges | -30.00% | -12.50% | 28.57% | 12.50% | 25.00% |
| Total Other Non-Cash Items | -25.38% | 57.79% | -40.55% | -20.60% | 4.42% |
| Change in Net Operating Assets | 199.39% | 61.50% | 112.34% | 75.78% | 53.14% |
| Cash from Operations | 95.72% | 59.68% | 402.52% | 96.93% | 17.93% |
| Capital Expenditure | 28.28% | -6.67% | 13.16% | -51.61% | 4.61% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -1,040.00% | 91.14% | -84.62% | -20.00% | 99.13% |
| Divestitures | 3,200.00% | -- | -95.08% | -91.22% | -92.31% |
| Other Investing Activities | -528.57% | -104.76% | 82.61% | -23.08% | 89.86% |
| Cash from Investing | -8.82% | 44.04% | -29.29% | -376.67% | 79.82% |
| Total Debt Issued | -33.33% | -14.29% | -32.87% | 500.00% | -99.79% |
| Total Debt Repaid | 1.54% | 2.38% | 25.36% | 94.88% | -71.05% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 56.00% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 5.23% | -47.93% | 6.70% | 31.20% | 19.47% |
| Cash from Financing | 31.83% | -37.18% | -654.55% | 77.37% | -137.77% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 149.71% | 183.92% | 411.11% | 90.41% | -586.11% |